In a study on the senescence of astrocytes in AD patients, senescent astrocytes showed upregulated expression of cyclin-dependent kinase inhibitor 2 A (CDKN2A) (also known as p16INK4a), which is a marker of senescence, in the frontal cortex of AD patients44. Here, CDKN2A is linked to Alzheimer disease.